| Daidzein | IC50 | 14000.0 [1] |
| Idazoxan | Ki | 10.0 [1], 28.0 [2] |
| Tracizoline | Ki | 1.91 [1] |
| 2-[1-(2-Biphenylyloxy)ethyl]-2-imidazoline | Ki | 1621.81 [1] |
| 2-(Phenoxymethyl)-4,5-dihydro-1H-imidazole | Ki | 0.89 [1] |
| 1H-Imidazole, 4,5-dihydro-2-(1-phenoxyethyl)- | Ki | 2691.53 [1] |
| 1-Benzylcyclopropylamine | Ki | 51000.0 [1], 480000.0 [2] |
| 7-O-Ethyldaidzein | IC50 | 300.0 [1] |
| 1H-Imidazole, 4,5-dihydro-2-[(1S,2S)-2-phenylcyclopropyl]- | Ki | 123.03 [1] |
| 7-(Allyloxy)-4'-hydroxyisoflavone | IC50 | 450.0 [1] |
| 11-(3-(4-Hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)undecanoic acid | IC50 | 13000.0 [1] |
| 10-(3-(4-Hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)decanoic acid | IC50 | 10000.0 [1] |
| 7-(6-Bromohexyloxy)-4'-hydroxyisoflavone | IC50 | 2000.0 [1] |
| 1H-Imidazole, 4,5-dihydro-2-[(1R,2R)-2-phenylcyclopropyl]- | Ki | 6.03 [1] |
| 7-O-w-Bromopropyldaidzein | IC50 | 150.0 [1] |
| 2-(2-Phenyl-cyclopropyl)-4,5-dihydro-1H-imidazole | Ki | 22.91 [1] |
| 7-(4-Bromobutoxy)-4'-hydroxyisoflavone | IC50 | 4000.0 [1] |
| 6-[3-(4-Hydroxy-phenyl)-4-oxo-4H-chromen-7-yloxy]-hexanoic acid | IC50 | 3000.0 [1], 4000.0 [2] |
| 7-[3-(4-Hydroxy-phenyl)-4-oxo-4H-chromen-7-yloxy]-heptanoic acid | IC50 | 2100.0 [1] |
| Fentanyl | Ki | 5462.0 [1] |
| Clonidine | Ki | 100.0 [1] |
| Genistein | IC50 | 900.0 [1] |
| Chrysin | IC50 | 1600.0 [1] |
| Rilmenidine | Ki | 10000.0 [1] |
| Biochanin A | IC50 | 400.0 [1] |
| 7,8-Dihydroxyflavone | IC50 | 17000.0 [1] |
| 7-Hydroxyflavone | IC50 | 120.0 [1] |
| 7,4'-Dihydroxyflavone | IC50 | 30.0 [1] |
| 7-Hydroxyflavanone | IC50 | 13000.0 [1] |
| 4'-Hydroxychalcone | IC50 | 4500.0 [1] |
| 7-Hydroxy-4-phenylcoumarin | IC50 | 500.0 [1] |
| 2-Imidazoline, 2-phenethyl- | Ki | 2.51 [1] |
| 2-(2-Biphenylyloxymethyl)-2-imidazoline | Ki | 302.0 [1] |
| 1H-Imidazole, 4,5-dihydro-2-(1-methyl-2-phenylethyl)- | Ki | 933.25 [1] |
| 2-[(1S)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 7244.36 [1] |
| 2-(2-Benzylphenoxymethyl)-2-imidazoline | Ki | 199.53 [1] |
| 3-(4-Hydroxyphenyl)-7-(carboxymethoxy)-4H-1-benzopyran-4-one | IC50 | 9000.0 [1] |
| 4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-(1-methylethoxy)- | IC50 | 200.0 [1] |
| 1H-Imidazole, 4,5-dihydro-2-[(1S)-1-methyl-2-phenylethyl]- | Ki | 144.54 [1] |
| 2-[1-(2-Benzylphenoxy)ethyl]-2-imidazoline | Ki | 7585.78 [1] |
| 2-[(1R)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole | Ki | 48977.88 [1] |
| Phenamazoline | Ki | 33.11 [1] |
| 2-(2-Biphenylylaminomethyl)-2-imidazoline | Ki | 812.83 [1] |
| 1-Phenylcyclopropanemethylamine | Ki | 50000.0 [1] |
| N-(Dicyclopropylmethyl)-2,3-dimethyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| N-(Dicyclopropylmethyl)-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| N-(Dicyclopropylmethyl)-3a,4,5,6,7,7a-hexahydro-3H-indol-2-amine | Ki | 10000.0 [1] |
| N-(Dicyclopropylmethyl)-2-ethyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| 2-[1-(4-Biphenylyloxy)ethyl]-2-imidazoline | Ki | 181.97 [1] |
| 8-(3-(4-Hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)octanoic acid | IC50 | 6500.0 [1] |
| 1H-Imidazole, 4,5-dihydro-2-[(2R)-2-phenylpropyl]- | Ki | 2511.89 [1] |
| 2-[1-(3-Biphenylyloxy)ethyl]-2-imidazoline | Ki | 269.15 [1] |
| 2-[(2R)-1-Phenylpropan-2-yl]-4,5-dihydro-1H-imidazole | Ki | 12589.25 [1] |
| N-[1-(4,5-Dihydro-1H-imidazol-2-yl)ethyl]-2-phenylaniline | Ki | 12589.25 [1] |
| 2-(2-Phenylpropyl)-2-imidazoline | Ki | 123.03 [1] |
| N-(3-Guanidino-propyl)-N-(1-phenethyl-piperidin-4-yl)-propionamide | Ki | 1920.0 [1] |
| N-(8-Guanidino-octyl)-N-(1-phenethyl-piperidin-4-yl)-propionamide | Ki | 126.0 [1] |
| N-(Dicyclopropylmethyl)-2-methyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| N-(Dicyclopropylmethyl)-4-methyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| (2R)-1-(4-Fluorophenyl)-N-methyl-N-prop-2-ynylpropan-2-amine | IC50 | 41.7 [1] |
| 5-(3-(4-Hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)pentanoic acid | IC50 | 5000.0 [1] |
| N-(Dicyclopropylmethyl)-3-methyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| N-(6-Guanidino-hexyl)-N-(1-phenethyl-piperidin-4-yl)-propionamide | Ki | 409.0 [1] |
| 7-(2,3-Dihydroxy-propoxy)-3-(4-hydroxy-phenyl)-chromen-4-one | IC50 | 1700.0 [1] |
| Ethyl 2-[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoctanoate | IC50 | 9000.0 [1] |
| 7-(5-Hexenyloxy)-4'-hydroxyisoflavone | IC50 | 5000.0 [1] |
| 7-(6-Hydroxyhexyloxy)-4'-hydroxyisoflavone | IC50 | 9000.0 [1] |
| 1H-Imidazole, 4,5-dihydro-2-[(2S)-2-phenylpropyl]- | Ki | 100.0 [1] |
| 7-[1-(Ethoxycarbonyl)ethoxy]-4'-hydroxyisoflavone | IC50 | 9000.0 [1] |
| 7-(9-Hydroxynonyloxy)-4'-hydroxyisoflavone | IC50 | 9000.0 [1] |
| 7-[4-(Ethoxycarbonyl)butoxy]-4'-hydroxyisoflavone | IC50 | 9000.0 [1] |
| 7-[5-(Ethoxycarbonyl)pentyloxy]-4'-hydroxyisoflavone | IC50 | 5300.0 [1] |
| 7-(2-Hydroxyethoxy)-4'-hydroxyisoflavone | IC50 | 1500.0 [1] |
| Ethyl 2-[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyhexanoate | IC50 | 9000.0 [1] |
| 1-[3-(4-Chlorophenyl)-5-(2,4-dihydroxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 20000.0 [1] |
| 1-[5-(4-Hydroxyphenyl)-3-(2-methoxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 30000.0 [1] |
| 1-[3-(2,4-Dimethoxyphenyl)-5-(4-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 10000.0 [1] |
| 1-[5-(4-Hydroxyphenyl)-3-(3-methylphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 9500.0 [1] |
| 1-[5-(4-Hydroxyphenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 3600.0 [1] |
| 1-[3-(3-Chlorophenyl)-5-(4-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 12000.0 [1] |
| 1-[3-(2-Chlorophenyl)-5-(4-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 50000.0 [1] |
| 1-[5-(4-Hydroxyphenyl)-3-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 200.0 [1] |
| 1-[5-(2,4-Dihydroxyphenyl)-3-(2-methoxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 40000.0 [1] |
| 1-[5-(2,4-Dihydroxyphenyl)-3-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 9500.0 [1] |
| 1-[5-(2,4-Dihydroxyphenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 10000.0 [1] |
| 1-[3-(4-Chlorophenyl)-5-(4-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]ethanone | IC50 | 40000.0 [1] |
| 7-O-[2-(1,3-Dioxanyl)ethyl]daidzein | IC50 | 7000.0 [1] |
| 6-[2-(4-Hydroxy-phenyl)-4-oxo-4H-chromen-7-yloxy]-hexanoic acid | IC50 | 7000.0 [1] |
| N-(2-Guanidino-ethyl)-N-(1-phenethyl-piperidin-4-yl)-propionamide | Ki | 437.0 [1] |
| N-(12-Guanidino-dodecyl)-N-(1-phenethyl-piperidin-4-yl)-propionamide | Ki | 6.5 [1] |
| 7-(4-Aminobutoxy)-4'-hydroxyisoflavone | IC50 | 9000.0 [1] |
| 7-(6-Aminohexyloxy)-4'-hydroxyisoflavone | IC50 | 9000.0 [1] |